Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PDHK-IN-5 is a potent inhibitor of PDHK, acting on PDHK2 (IC50: 0.006 μM) and PDHK4 (IC50: 0.0329 μM), which are drug targets for many diseases including diabetes and cancer. PDHK-IN-5 has the potential to be investigated in cancer diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | PDHK-IN-5 is a potent inhibitor of PDHK, acting on PDHK2 (IC50: 0.006 μM) and PDHK4 (IC50: 0.0329 μM), which are drug targets for many diseases including diabetes and cancer. PDHK-IN-5 has the potential to be investigated in cancer diseases. |
Molecular Weight | 493.6 |
Formula | C30H31N5O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.